JT
Jeffrey Tong
Partner at Third Rock Ventures
JT
Jeffrey Tong
Partner at Third Rock Ventures
Menlo Park, California
Overview
Work Experience
Partner
2016 - Current
Focused on building innovative companies to serve patients with significant unmet medical needs. ARTBIO - Board member Asher Biotherapeutics - Board member Candid Therapeutics - Board member Marea Therapeutics - Board member Maze Therapeutics - Board member Rapport Therapeutics (RAPP) - Board member Septerna - Chairman of the board Past companies: Ambys Medicines Nurix (NRIX) Terremoto Biosciences
Executive Chairman of the Board
2016 - 2017
Served as Executive Chairman and Chairman through $35M Series A financing and subsequent acquisition by Celgene for $775M with $300M upfront.
Member of the Board of Directors
2010 - 2016
President & CEO
2010 - 2015
Vice President, Corporate and Product Development
2001 - 2010
Consultant
2000 - 2001
Education
AB, AM, MMS, PhD
1992 - 2000